Structure-based drug design of non-nucleoside inhibitors for wild-type and drug-resistant HIV reverse transcriptase.
@article{Mao2000StructurebasedDD, title={Structure-based drug design of non-nucleoside inhibitors for wild-type and drug-resistant HIV reverse transcriptase.}, author={C. Mao and E. Sudbeck and T. Venkatachalam and F. Uckun}, journal={Biochemical pharmacology}, year={2000}, volume={60 9}, pages={ 1251-65 } }
The generation of anti-HIV agents using structure-based drug design methods has yielded a number of promising non-nucleoside inhibitors (NNIs) of HIV reverse transcriptase (RT). Recent successes in identifying potent NNIs are reviewed with an emphasis on the recent trend of utilizing a computer model of HIV RT to identify space in the NNI binding pocket that can be exploited by carefully chosen functional groups predicted to interact favorably with binding pocket residues. The NNI binding… CONTINUE READING
Topics from this paper
54 Citations
Novel tight binding PETT, HEPT and DABO-based non-nucleoside inhibitors of HIV-1 reverse transcriptase
- Biology, Medicine
- Journal of enzyme inhibition and medicinal chemistry
- 2006
- 22
The search for potent, small molecule NNRTIs: A review.
- Biology, Medicine
- Bioorganic & medicinal chemistry
- 2009
- 57
HIV‐1 NNRTIs: structural diversity, pharmacophore similarity, and impliations for drug design
- Biology, Medicine
- Medicinal research reviews
- 2013
- 145
Flexible docking of pyridinone derivatives into the non-nucleoside inhibitor binding site of HIV-1 reverse transcriptase.
- Chemistry, Medicine
- Bioorganic & medicinal chemistry
- 2004
- 11
Comparative study of non nucleoside inhibitors with HIV-1 reverse transcriptase based on 3D-QSAR and docking
- Chemistry, Medicine
- SAR and QSAR in environmental research
- 2003
- 14
- Highly Influenced
Dawn of non-nucleoside inhibitor-based anti-HIV microbicides.
- Biology, Medicine
- The Journal of antimicrobial chemotherapy
- 2006
- 96
- PDF
Steered molecular dynamics simulation on the binding of NNRTI to HIV-1 RT.
- Chemistry, Medicine
- Biophysical journal
- 2003
- 64
- PDF
Effect of stereo and regiochemistry towards wild and multidrug resistant HIV-1 virus: viral potency of chiral PETT derivatives.
- Chemistry, Medicine
- Biochemical pharmacology
- 2004
- 17
Theoretical studies on the molecular basis of HIV-1RT/NNRTIs interactions
- Chemistry, Medicine
- Journal of enzyme inhibition and medicinal chemistry
- 2011
- 6
Effect of stereochemistry on the anti-HIV activity of chiral thiourea compounds.
- Chemistry, Medicine
- Bioorganic & medicinal chemistry
- 2004
- 112
References
SHOWING 1-10 OF 63 REFERENCES
The structure of HIV-1 reverse transcriptase complexed with 9-chloro-TIBO: lessons for inhibitor design.
- Biology, Medicine
- Structure
- 1995
- 159
Structures of Tyr188Leu mutant and wild-type HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor HBY 097: inhibitor flexibility is a useful design feature for reducing drug resistance.
- Biology, Medicine
- Journal of molecular biology
- 1998
- 105
The PETT series, a new class of potent nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
- Biology, Medicine
- Antimicrobial agents and chemotherapy
- 1995
- 82
- PDF
Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance.
- Biology, Medicine
- Journal of molecular biology
- 1994
- 487
Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1.
- Biology, Medicine
- Proceedings of the National Academy of Sciences of the United States of America
- 1994
- 285
- PDF
Unique features in the structure of the complex between HIV-1 reverse transcriptase and the bis(heteroaryl)piperazine (BHAP) U-90152 explain resistance mutations for this nonnucleoside inhibitor.
- Biology, Medicine
- Proceedings of the National Academy of Sciences of the United States of America
- 1997
- 168
- PDF
The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection
- Biology
- 1998
- 264
Novel concepts in the treatment of human immunodeficiency virus type 1 (HIV-1) infections by HIV-1-specific reverse transcriptase inhibitors.
- Biology, Medicine
- Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie
- 1995
- 2
Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors.
- Chemistry, Medicine
- Journal of medicinal chemistry
- 1996
- 271